U.S. Chamber Highlights Priorities in Corporate Prosecution Reform

But rather than stress broad FCPA reform, the business lobby this year is focusing on the subsidiary issue of prosecution declinations, while also spotlighting hard-ball “exclusion” tactics used against companies in health care fraud enforcement.

This story is exclusively for members of the
JUST ANTI-CORRUPTION COMMUNITY
Log-in
E-mail Address or UserName: *
Password: *
Subscribe
Click here to subscribe to
Just Anti-Corruption


For information about pricing, click here.
Ernst & Young LLP
Dealing with complex issues of fraud, regulatory compliance and business disputes can detract from efforts to succ... more
Barnes & Thornburg LLP
ANALYSIS: Conviction of Private Investigators in China Further Complicates Anti-Corruption Compliance Efforts more
Arnall Golden Gregory LLP
ANALYSIS: Costly FCPA Misconceptions more
McGuireWoods LLP
ANALYSIS: The Long Arm of British Anti-Corruption Laws and the Impact on Individual Defendants more
Arnold & Porter LLP
ANALYSIS: Never Been To The U.S.? You May Still Be Charged Under The FCPA  more
Zuckerman Spaeder LLP
ANALYSIS: Five Takeaways from the Second Circuit’s Dodd-Frank Decision in Liu v. Siemens more
Dorsey & Whitney LLP
ANALYSIS: Anti-Corruption Campaign in China – Causes of Corruption, and Hope? more

LATEST SPECULATION ABOUT HOLDER'S DEPARTURE:He's always supposed to have one foot out the door.

USDOJ: CRIMINAL DIVISION NEWS  
An error has occurred, which probably means the feed is down. Try again later.